Abstract
Depressed elderly persons frequently have concurrent symptoms of anxiety or comorbid anxiety disorders. Such comorbidity is associated with a more severe presentation of depressive illness, including greater suicidality. Additionally, most antidepressant treatment studies in the elderly have found poorer treatment outcomes in those with comorbid anxiety (including delayed or diminished response and increased likelihood of dropout from treatment).
While antidepressants such as selective serotonin reuptake inhibitors and tricyclic agents are efficacious for late-life depression, there is no evidence that either class is superior, in terms of efficacy or tolerability, in the treatment of anxious depression. Rather, the amount and quality of clinical management, and not the particular medication chosen, appears to influence the likelihood of remission or treatment withdrawal in anxious depressed elderly patients. Co-prescription of benzodiazepines, typically lorazepam, is also warranted in some cases for severe anxiety or insomnia, but carries the risk of cognitive or motor impairment.
It is our experience that close clinical monitoring, together with maximisation of antidepressant treatment (by maximising dosage, augmenting or switching agents in cases of partial or no response, and/or adding psychotherapy) will almost always result in remission of depressive symptoms, together with improvement of anxiety, in these individuals. Therefore, optimism should be maintained when treating the depressed elderly individual, even when comorbid anxiety is present.
Similar content being viewed by others
References
Beekman AT, de Beurs E, van Balkom AJ, et al. Anxiety and depression in later life: co-occurrence and communality of risk factors. Am J Psychiatry 2000; 157: 89–95
Parmelee P, Katz I, Lawton MP. Anxiety and its association with depression among institutionalized elderly. Am J Geriatr Psychiatry 1993; 1: 65–78
Kessler RC, McGonagle KA, Zhao S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Survey. Arch Gen Psychiatry 1994; 51: 8–19
Mulsant BH, Reynolds CF, Shear MK, et al. Comorbid anxiety disorders in late-life depression. Anxiety 1996; 2: 242–7
Flint AJ. Epidemiology and comorbidity of anxiety disorders in the elderly. Am J Psychiatry 1994; 151: 640–9
Lenze EJ, Mulsant BH, Shear MK, et al. Comorbid anxiety disorders in depressed elderly patients. Am J Psychiatry 2000; 157: 722–8
American Psychiatric Association. DSM-IV. Washington (DC): American Psychiatric Association, 1994
Burvill PW, Johnson GA, Jamrozik KD, et al. Anxiety disorders after stroke: results from the Perth Community Stroke Study. Br J Psychiatry 1995; 166: 328–32
Moser DK, Dracup K. Is anxiety early after myocardial infarction associated with subsequent ischemic and arrhythmic events? Psychosom Med 1996; 58: 395–401
Lenze EJ, Mulsant BH, Shear MK, et al. Comorbidity of depression and anxiety disorders in later life. Depress Anxiety 2001; 14: 86–93
Allgulander C, Lavori PW. Causes of death among 936 elderly patients with ‘pure’ anxiety neurosis in Stockholm County, Sweden, and in patients with depressive neurosis or both diagnoses. Compr Psychiatry 1993; 34: 299–302
Conwell Y. Suicide in elderly patients. In: Schneider LS, Reynolds CF, Lebowitz BD, editors. Diagnosis and treatment of depression in late life. Washington (DC): American Psychiatric Press, Inc., 1996: 397–418
Szanto K, Gildengers AG, Mulsant BH, et al. Identification of suicidal ideation and prevention of suicidal behaviour in the elderly. Drugs Aging 2002; 19: 11–24
Fawcett J. The detection and consequences of anxiety in clinical depression. J Clin Psychiatry 1997; 58Suppl. 8: 35–40
Flint AJ, Rifat SL. Anxious depression in elderly patients: response to antidepressant treatment. Am J Geriatr Psychiatry 1997; 5: 107–15
Dew MA, Reynolds CF, Houck PR, et al. Temporal profiles of the course of depression during treatment: predictors of pathways toward recovery in the elderly. Arch Gen Psychiatry 1997; 54: 1016–24
Lenze EJ, Mulsant BH, Dew MA, et al. Good treatment outcomes in late-life depression with comorbid anxiety. J Affect Disord. In press
Mulsant BH, Alexopoulos GS, Reynolds CF, et al. Pharmacologic treatment of depression in elderly primary care patients: The PROSPECT algorithm. Int J Geriatr Psychiatry 2001; 16: 585–92
Snaith RP, Baugh SJ, Clayden AD, et al. The clinical anxiety scale: an instrument derived from the Hamilton Anxiety Scale. Br J Psychiatry 1982; 141: 518–23
Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23: 56–62
Rollman BL, Block MR, Schulberg HC. Major depression and tricyclic side effects in primary care patients. J Gen Intern Med 1997; 12: 284–91
Mulsant BH, Pollock B. Treatment-resistant depression in late-life. J Geriatr Psychiatry Neurol 1998; 11: 186–93
Flint AJ, Rifat SL. Two-year outcome of elderly patients with anxious depression. Psychiatry Res 1997; 66: 23–31
Meyers BS, Gabriele MS, Kakuma T, et al. Anxiety and recurrence as predictors of recurrence in geriatric depression: a preliminary report. Am J Geriatr Psychiatry 1996; 4: 252–7
Shelton RC, Tomarken AJ. Can recovery from depression be achieved? Psychiatr Serv 2001; 52(11): 1469–78
Mulsant BH, Pollock BG, Nebes R, et al. A twelve-week double-blind randomized comparison of nortriptyline and paroxetine in older depressed inpatients and outpatients. Am J Geriatr Psychiatry 2001; 9: 406–14
Bondareff W, Alpert M, Friedhoff AJ, et al. Comparison of sertraline and nortriptyline in the treatment of major depressive disorder in late life. Am J Psychiatry 2000; 157: 729–36
Alexopoulos GS, Katz I, Reynolds CF, et al. Pharmacotherapy of depressive disorders in older patients. In: Roberts WO, editor. Postgraduate medicine special report. Minn (MN): McGraw-Hill Companies; 2001: 1–86
Furukawa TA, Streiner DL, Young LT. Is antidepressant-benzodiazepine combination therapy clinically more useful?: a meta-analytic study. J Affect Disord 2001; 65: 173–7
Leipzig RM, Cumming RG, Tinetti ME. Drugs and falls in older people: a systematic review and meta-analysis: I. psychotropic drugs. J Am Geriatr Soc 1999; 47: 30–9
Hanlon JT, Horner RD, Schmader KE, et al. Benzodiazepine use and cognitive function among community-dwelling elderly. Clin Pharmacol Ther 1998; 64: 684–92
Buysse DJ, Reynolds CF, Houck PR, et al. Does lorazepam impair the antidepressant response to nortriptyline and psychotherapy? J Clin Psychiatry 1997; 58: 426–32
Wells KB, Burnam MA. Caring for depression in America: lessons learned from early findings of the Medical Outcomes Study. Psychiatr Med 1991; 9: 503–19
Prudic J, Haskett RF, Mulsant BH, et al. Resistance to antidepressant medications and short-term clinical response to ECT. Am J Psychiatry 1996; 153: 985–92
Mulsant BH, Rosen J, Thornton JE, et al. A prospective naturalistic study of electroconvulsive therapy in late-life depression. J Geriatr Psychiatry Neurol 1991; 4: 3–13
Tew JD, Mulsant BH, Haskett RF. Acute efficacy of ECT in the treatment of major depression in the old-old. Am J Psychiatry 1999; 156: 1865–70
Fink M. ECT in anxiety: an appraisal. Am J Psychother 1982; 36: 371–8
Acknowledgements
Supported by NIMH grants K23 MH64196, P30 MH 52247, K05 MH00295, K01 MH01613, R37 MH43832, R01 MH37869, and T32 MH19986. The authors have no conflicts of interest that are directly relevant to the content of this manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lenze, E.J., Mulsant, B.H., Shear, M.K. et al. Anxiety Symptoms in Elderly Patients with Depression. Drugs Aging 19, 753–760 (2002). https://doi.org/10.2165/00002512-200219100-00004
Published:
Issue Date:
DOI: https://doi.org/10.2165/00002512-200219100-00004